Mylan is a global pharmaceutical company founded in 1961 with a mission to provide access to high quality medicines worldwide. It has grown significantly over the years, including through acquisitions like Matrix Laboratories in India in 2007 that made Mylan one of the largest API manufacturers. Mylan and Pfizer's Upjohn division recently announced a merger to form a new company called Viatris, which will combine Mylan's generics portfolio and Upjohn's off-patent brands. The new company will have leadership from both Mylan and Pfizer and sell products in 165 markets worldwide.

1. Presented by
Ch. S S N D Balakrishna, M.Pharm
Department of Regulatory Affairs
Shri Vishnu college of pharmacy
1

2. Introduction
• Mylan is a global pharmaceutical company committed to set
new standards in healthcare and providing 7 billion people
access to high quality medicines available to everyone who
needs them.
• Founded in the U.S. in 1961 and became a leading
manufacturer.
1

3. Mission
At Mylan, they are committed to set new standards in healthcare. Working
together around the world to provide 7 billion people access to high quality
medicine, they:
• Innovate to satisfy unmet needs;
• Make reliability and service excellence a habit;
• Do what's right, not what's easy; and
• Impact the future through passionate global leadership.
2

4. Mylan track record

5. History of Mylan
• 1961: Milan Puskar and Don Panoz, who met while
serving in the U.S Army, found Milan Pharmaceuticals
as a drug distributor in White Sulphur Springs, West
Virginia in a formal skating rink.
• 1965:The company started manufacturing Penicillin-G
tablets as well as vitamins and other dietary
supplements. After receiving FDA approval. Milan
changed its name to Mylan Laboratories Inc.
4

6. History of Mylan
• Panoz left Mylan in 1969 and Puskar quit the company in
1973, as it grew and experienced financial difficulties.
• The board hired Roy McKnight as CEO, and he brings
Puskar back in 1976 as president.
• 1984, Mylan introduced its first proprietary drug,
Maxzide. Generated $100 million in sales by 1988.
• 1993, McKnight dies suddenly due to heart attack, and
Puskar is named chairman and CEO
5

7. Mylan in India
Mylan’s business in India began in 2007 with the acquisition
of Matrix Laboratories Limited (19 manufacturing facilities).
The deal transformed Mylan overnight into one the world’s
largest manufacturers of API.
Manufacturing presence in India
India: 19 manufacturing facilities
8 API, 6 OSD,5 INJ
Regulatory track record: 17 of Mylan’s facilities in India (5
OSD, 8 API, 4 Injectables) are approved by the U.S. Food and
Drug Administration
6

8. Awards
• Mylan wins the PHARMEXCIL award for Outstanding Export Performance
for its commendable contribution towards Pharmaceuticals export in India for
the year 2017-18.
8

9. Pfizer Upjohn to merge its off-patent drug unit
with Mylan
• The name of the new company to be formed by the planned combination
of Mylan and Upjohn, a division of Pfizer, will be ”VIATRIS.”
• (“VIA”to three“TRIS”core goals.)
• This NewCo will continue sales of Mylan's more than 7,500 products including
biosimilars, generics, brand and over the counter remedies. Pfizer's Upjohn unit
including Lipitor (atorvastatin calcium), Celebrex (celecoxib) and Viagra
(sildenafil) According to the joint press releases the NewCo will sell products in
165 markets.
10

10. Pfizer Upjohn to merge its off-patent drug unit
with Mylan 10
• Pfizer shareholders would own 57% of the
combined new company, and Mylan
shareholders would own 43%. The Boards of
Directors of both Mylan and Pfizer have
unanimously approved the transaction.
• Mylan’s current CEO HEATHER BRESCH,
will retire from Mylan upon the close of this
transaction.
• MICHAEL GOETTLER, current Group
President, of the Upjohn division of Pfizer
will serve as Chief Executive Officer (CEO);

11. Thank You